Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient, surgically resectable endometrial cancer.

In a study of patients with advanced melanoma, the prevalence of cutaneous immune–related adverse events (cirAEs) associated with nivolumab/relatlimab combination therapy was 21.5%, with rash ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published.

Pembrolizumab (Keytruda), nivolumab (Opdivo), and ipilimumab (Yervoy ... drugs are similar to those caused by tebentafusp (skin rash, fatigue, nausea), as well as: Cough Poor appetite Constipation ...

received nivolumab and ipilimumab. Table 2 summarizes the clinical manifestations of 31 patients. The main skin symptoms of the patients were bullae/blisters (20 cases, 64.5%), erythema (17 cases, ...

ICIs provide clinical benefits in a percentage of patients with advanced cancers, but they are usually associated with a remarkable spectrum of immune-related adverse events (irAEs) (e.g., rash ... (5 ...

Treatment-related adverse events (>=10%) were low grade (1-2) and included xerostomia (76%), fatigue (43%), nausea (24%), rash (22%), pruritus (19% ... Arm A 177 Lu-PSMA-617 + induction ipilimumab + ...

That seemingly harmless rash inside your mouth could be trying to tell you something important about your health. While most people dismiss oral irritations as minor nuisances, medical experts ...

Also known as polymorphic eruption of pregnancy (PEP), it is one of the most common types of rash you can get during pregnancy. Though harmless, it does cause an itchy rash with hive-like bumps on ...